38
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Treatment of Chronic Lymphocytic Leukemia: A Preliminary Report of Spanish (Pethema) Trials

Pages 89-91 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ciril Rozman & Emilio Montserrat. (1997) Chronic Lymphocytic Leukemia: An Update on Current Treatment Approaches. Hematology 2:1, pages 1-9.
Read now

Articles from other publishers (27)

Salem H Alshemmari, Mustaqeem A. Siddiqui, Ramesh Pandita, Hani Y. Osman, Honar Cherif, Susan O'Brien, Mahmoud Marashi & Khalil Al Farsi. (2023) Evidence-based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf Region. Acta Haematologica.
Crossref
Piotr Ladyzynski, Maria Molik & Piotr Foltynski. (2022) Dynamic Bayesian networks for prediction of health status and treatment effect in patients with chronic lymphocytic leukemia. Scientific Reports 12:1.
Crossref
Michael Hallek & Othman Al‐Sawaf. (2021) Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures. American Journal of Hematology 96:12, pages 1679-1705.
Crossref
Nil Albiol, Miguel Arguello-Tomas & Carol Moreno. (2021) The road to chemotherapy-free treatment in chronic lymphocytic leukaemia. Current Opinion in Oncology 33:6, pages 670-680.
Crossref
Dianna Hussmann, Anna Starnawska, Louise Kristensen, Iben Daugaard, Astrid Thomsen, Tina E. Kjeldsen, Christine Søholm Hansen, Jonas Bybjerg-Grauholm, Karina Dalsgaard Johansen, Maja Ludvigsen, Thomas Kristensen, Thomas Stauffer Larsen, Michael Boe Møller, Charlotte Guldborg Nyvold, Lise Lotte Hansen & Tomasz K. Wojdacz. (2021) IGHV-associated methylation signatures more accurately predict clinical outcomes of chronic lymphocytic leukemia patients than IGHV mutation load. Haematologica 107:4, pages 877-886.
Crossref
Michael Hallek. (2019) Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment. American Journal of Hematology 94:11, pages 1266-1287.
Crossref
Michael Hallek. (2017) Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment. American Journal of Hematology 92:9, pages 946-965.
Crossref
Tadeusz Robak, Stephan Stilgenbauer & Alessandra Tedeschi. (2017) Front-line treatment of CLL in the era of novel agents. Cancer Treatment Reviews 53, pages 70-78.
Crossref
Michael Hallek. (2015) Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment. American Journal of Hematology 90:5, pages 446-460.
Crossref
Piotr Ladyzynski, Maria Molik & Piotr Foltynski. (2015) A network meta-analysis of progression free survival and overall survival in first-line treatment of chronic lymphocytic leukemia. Cancer Treatment Reviews 41:2, pages 77-93.
Crossref
Teruhiko Terasawa, Nikolaos A. Trikalinos, Benjamin Djulbegovic & Thomas A. Trikalinos. (2013) Comparative efficacy of first-line therapies for advanced-stage chronic lymphocytic leukemia: A multiple-treatment meta-analysis. Cancer Treatment Reviews 39:4, pages 340-349.
Crossref
Michael HallekBruce D. ChesonDaniel CatovskyFederico Caligaris-CappioGuillaume DighieroHartmut DöhnerPeter HillmenMichael J. KeatingEmili MontserratKanti R. Rai & Thomas J. Kipps. (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines. Blood 111:12, pages 5446-5456.
Crossref
Pierre Soubeyran & Alain Monnereau. 2007. Cancer du sujet âgé. Cancer du sujet âgé 179 206 .
Stefan Faderl, William Wierda & Michael J. Keating. (2006) New aspects of the treatment of chronic lymphocytic leukemia. Current Hematologic Malignancy Reports 1:4, pages 251-257.
Crossref
Alessandra Ferrajoli, Michael J. Keating & Susan M. O’Brien. 2004. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia 241 254 .
Guillaume Dighiero. 2004. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia 219 240 .
Gerassimos A. Pangalis, Theodoros P. Vassilakopoulos, Maria N. Dimopoulou, Marina P. Siakantaris, Flora N. Kontopidou & Maria K. Angelopoulou. (2002) B‐chronic lymphocytic leukemia: practical aspects. Hematological Oncology 20:3, pages 103-146.
Crossref
Ramón García-Sanz, Silvia Montoto, Agustín Torrequebrada, Alfonso García De Coca, José Petit, Anna Sureda, José Antonio Rodríguez-García, Pilar Massó, Ana Pérez-Aliaga, María Dolores Monteagudo, Isabel Navarro, Gemma Moreno, Carmen Toledo, Aránzazu Alonso, Carles Besses, Joan Besalduch, Isidro Jarque, Perla Salama, José Angel Hernández Rivas, Blanca Navarro, Joan Bladé & Jesús F. San Miguel. (2001) Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases. British Journal of Haematology 115:3, pages 575-582.
Crossref
Nelson Kalil & Bruce D. Cheson. (2000) Management of Chronic Lymphocytic Leukaemia. Drugs & Aging 16:1, pages 9-27.
Crossref
Branimir Jaksic, Maura Brugiatelli, Ivo Krc, Hajna Losonczi, Jerzy Holowiecki, Ana Planinc-Peraica, Rajko Kusec, Fortunato Morabito, Pasquale Iacopino & Dieter Lutz. (1997) High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Cancer 79:11, pages 2107-2114.
Crossref
F. Morabito, I. Callea, G. Irrera, G. Cartisano, A. Dattola, A. Rodinò & M. Brugiatelli. (2009) In vitro improvement of chlorambucil‐induced cytotoxicity by deflazacort and 6‐methylprednisolone in B‐cell chronic lymphocytic leukaemia . European Journal of Haematology 58:5, pages 301-306.
Crossref
E. Montserrat, F. Bosch & C. Rozman. (1997) B-cell chronic lymphocytic leukemia: Recent progress in biology, diagnosis, and therapy. Annals of Oncology 8, pages S93-S101.
Crossref
E. Montserrat, F. Bosch & C. Rozman. 1997. Acute Leukemias VI. Acute Leukemias VI 341 348 .
The French Cooperative Group on CLL, S Johnson, A.G Smith, H Löffler, E Ösby, G Juliusson, B Emmerich, P.J Wyld & W Hiddemann. (1996) Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The Lancet 347:9013, pages 1432-1438.
Crossref
Ciril Rozman & Emilio Montserrat. (1995) Chronic Lymphocytic Leukemia. New England Journal of Medicine 333:16, pages 1052-1057.
Crossref
M. Brugiatelli, B. Jaksic, A. Planinc‐Peraica, R. Kusec, S. Ostojic, V. Callea, P. Lacopino, F. Morabito, C. Stelitano & D. Lutz. (2009) Treatment of chronic lymphocytic leukemia in early and stable phase of the disease: Long‐term results of a randomized trial. European Journal of Haematology 55:3, pages 158-163.
Crossref
E. Montserrat & C. Rozman. (1995) Chronic lymphocytic leukemia: Present status. Annals of Oncology 6:3, pages 219-235.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.